# Lidocaine-Prilocaine Cream (EMLA) Topical Application Versus Wound Infiltration With Lidocaine After Cesarean Section

> **NCT02549105** · PHASE4 · UNKNOWN · sponsor: **Ain Shams Maternity Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Post Operative Pain

## Interventions

- **DRUG:** EMLA CREAM 5 mg
- **DRUG:** LIDOCAINE 1 %

## Key facts

- **NCT ID:** NCT02549105
- **Lead sponsor:** Ain Shams Maternity Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2015-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02549105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02549105, "Lidocaine-Prilocaine Cream (EMLA) Topical Application Versus Wound Infiltration With Lidocaine After Cesarean Section". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02549105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*